Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324

ClinicalTrials.gov ID: NCT07484074

Public ClinicalTrials.gov record NCT07484074. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 12:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Two Different Formulations of Intravitreal OLN324 in Adult Participants With Either Neovascular (Wet) Age-related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324

Study identification

NCT ID
NCT07484074
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Ollin Biosciences, Inc.
Industry
Enrollment
164 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 12, 2025 (Actual)
Primary completion
Oct 10, 2025 (Actual)
Completion
Dec 9, 2025 (Actual)
Last update posted
Mar 19, 2026

2025

United States locations

U.S. sites
29
U.S. states
13
U.S. cities
29
Facility City State ZIP Site status
Phoenix, AZ Phoenix Arizona 85016 —
Glendale, CA Glendale California 91204 —
Pasadena, CA Pasadena California 91107 —
Sacramento, CA Sacramento California 95825 —
Walnut Creek, CA Walnut Creek California 94598 —
Waterford, CT Waterford Connecticut 06385 —
Fort Myers, FL Fort Myers Florida 33912 —
Saint Petersburg, FL St. Petersburg Florida 33711 —
Winter Haven, FL Winter Haven Florida 33880 —
Oak Forest, IL Oak Forest Illinois 60452 —
Hagerstown, MD Hagerstown Maryland 21740 —
Grand Rapids, MI Grand Rapids Michigan 49546 —
Reno, NV Reno Nevada 89502 —
Wake Forest, NC Wake Forest North Carolina 27587 —
Tulsa, OK Tulsa Oklahoma 74114 —
Springfield, OR Springfield Oregon 97477 —
Germantown, TN Germantown Tennessee 38138 —
Abilene, TX Abilene Texas 79606 —
Arlington, TX Arlington Texas 76012 —
Austin, TX Austin Texas 78705 —
Bellaire, TX Bellaire Texas 77401 —
Dallas, TX Dallas Texas 75231 —
Katy, TX Katy Texas 77494 —
Plano, TX Plano Texas 75075 —
Round Rock, TX Round Rock Texas 78681 —
San Antonio, TX San Antonio Texas 78240 —
San Marcos, TX San Marcos Texas 78666 —
Schertz, TX Schertz Texas 78154 —
The Woodlands, TX The Woodlands Texas 77384 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07484074, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 19, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07484074 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →